BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol 2010;105:2276-86. [PMID: 20502447 DOI: 10.1038/ajg.2010.201] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Kleeff J, Whitcomb DC, Shimosegawa T, Esposito I, Lerch MM, Gress T, Mayerle J, Drewes AM, Rebours V, Akisik F, Muñoz JED, Neoptolemos JP. Chronic pancreatitis. Nat Rev Dis Primers 2017;3. [DOI: 10.1038/nrdp.2017.60] [Cited by in Crossref: 168] [Cited by in F6Publishing: 128] [Article Influence: 42.0] [Reference Citation Analysis]
2 Aleotti F, Nano R, Piemonti L, Falconi M, Balzano G. Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy. Updates Surg 2021;73:1237-46. [PMID: 34319573 DOI: 10.1007/s13304-021-01129-w] [Reference Citation Analysis]
3 Toskes PP, Secci A, Thieroff-Ekerdt R; ZENPEP Study Group. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis. Pancreas. 2011;40:376-382. [PMID: 21343835 DOI: 10.1097/mpa.0b013e31820b971c] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
4 Lambré C, Barat Baviera JM, Bolognesi C, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, Mengelers M, Mortensen A, Rivière G, Steffensen IL, Tlustos C, Van Loveren H, Vernis L, Zorn H, Gundert-Remy U, Herman L, Turck D, Engel KH, Aguilera-Gómez M, Andryszkiewicz M, Kovalkovicova N, Liu Y, Maia J, Rainieri S, Chesson A; EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP). Safety evaluation of a food enzyme containing trypsin and chymotrypsin from porcine pancreas. EFSA J 2021;19:e06640. [PMID: 34140999 DOI: 10.2903/j.efsa.2021.6640] [Reference Citation Analysis]
5 Whitcomb DC, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, Pollack PF, Khurmi RP. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Pancreas 2016;45:679-86. [PMID: 26495784 DOI: 10.1097/MPA.0000000000000514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chaudhary A, Domínguez-Muñoz JE, Layer P, Lerch MM. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy. Dig Dis 2020;38:53-68. [PMID: 31422398 DOI: 10.1159/000501675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
7 Kim H, Yoon Y, Han Y, Kwon W, Kim S, Han H, Yoon D, Park JS, Park S, Han S, Lee SE, Choi SH, Han IW, Kim E, Jang J. Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized Trial. Clinical Gastroenterology and Hepatology 2020;18:926-934.e4. [DOI: 10.1016/j.cgh.2019.08.061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
8 Paulo JA, Kadiyala V, Lee LS, Banks PA, Conwell DL, Steen H. Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis. J Proteome Res 2012;11:1897-912. [PMID: 22243521 DOI: 10.1021/pr2011022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
9 de-Madaria E, Abad-gonzález Á, Aparicio JR, Aparisi L, Boadas J, Boix E, de las Heras G, Domínguez-muñoz E, Farré A, Fernández-cruz L, Gómez L, Iglesias-garcía J, García-malpartida K, Guarner L, Lariño-noia J, Lluís F, López A, Molero X, Moreno-pérez Ó, Navarro S, Palazón JM, Pérez-mateo M, Sabater L, Sastre Y, Vaquero EC, Martínez J. Recomendaciones del Club Español Pancreático para el diagnóstico y tratamiento de la pancreatitis crónica: parte 2 (tratamiento). Gastroenterología y Hepatología 2013;36:422-36. [DOI: 10.1016/j.gastrohep.2012.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Calvo-Lerma J, Fornés-Ferrer V, Peinado I, Heredia A, Ribes-Koninckx C, Andrés A. A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis. PLoS One 2019;14:e0212459. [PMID: 30794618 DOI: 10.1371/journal.pone.0212459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Benini L, Gabbrielli A, Cristofori C, Amodio A, Butturini G, Cardobi N, Sozzi C, Frulloni L, Mucelli RP, Crinò S, Bassi C, Marchegiani G, Andrianello S, Malleo G, Salvia R. Residual pancreatic function after pancreaticoduodenectomy is better preserved with pancreaticojejunostomy than pancreaticogastrostomy: A long-term analysis. Pancreatology 2019;19:595-601. [PMID: 31005377 DOI: 10.1016/j.pan.2019.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Trang T, Chan J, Graham DY. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century. World J Gastroenterol 2014;20:11467-85. [PMID: 25206255 DOI: 10.3748/wjg.v20.i33.11467] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
13 Gubergrits N, Malecka-Panas E, Lehman GA, Vasileva G, Shen Y, Sander-Struckmeier S, Caras S, Whitcomb DC. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther. 2011;33:1152-1161. [PMID: 21418260 DOI: 10.1111/j.1365-2036.2011.04631.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
14 Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther 2013;37:691-702. [PMID: 23383603 DOI: 10.1111/apt.12236] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
15 Working Party of the Australasian Pancreatic Club. Smith RC, Smith SF, Wilson J, Pearce C, Wray N, Vo R, Chen J, Ooi CY, Oliver M, Katz T, Turner R, Nikfarjam M, Rayner C, Horowitz M, Holtmann G, Talley N, Windsor J, Pirola R, Neale R. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016;16:164-180. [PMID: 26775768 DOI: 10.1016/j.pan.2015.12.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
16 Kuhn RJ, Gelrud A, Munck A, Caras S. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. Adv Therapy 2010;27:895-916. [DOI: 10.1007/s12325-010-0085-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
17 Caras S, Boyd D, Zipfel L, Sander-Struckmeier S. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency. J Pediatr Gastroenterol Nutr 2011;53:634-40. [PMID: 21681115 DOI: 10.1097/MPG.0b013e3182281c38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Shandro BM, Nagarajah R, Poullis A. Challenges in the management of pancreatic exocrine insufficiency. World J Gastrointest Pharmacol Ther 2018;9:39-46. [PMID: 30397535 DOI: 10.4292/wjgpt.v9.i5.39] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
19 Saito T, Nakai Y, Isayama H, Hirano K, Ishigaki K, Hakuta R, Takeda T, Saito K, Umefune G, Akiyama D, Watanabe T, Takagi K, Takahara N, Hamada T, Uchino R, Mizuno S, Mouri D, Yagioka H, Kogure H, Togawa O, Matsubara S, Ito Y, Yamamoto N, Tada M, Koike K. A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer. Pancreas. 2018;47:800-806. [PMID: 29851751 DOI: 10.1097/mpa.0000000000001079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Marra-Lopez Valenciano C, Bolado Concejo F, Marín Serrano E, Millastre Bocos J, Martínez-Moneo E, Pérez Rodríguez E, Francisco González M, Del Pozo-García A, Hernández Martín A, Labrador Barba E, Orera Peña ML, de-Madaria E. Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL Study. Gastroenterol Hepatol 2018;41:77-86. [PMID: 28935122 DOI: 10.1016/j.gastrohep.2017.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
21 Barreto SG, Saccone GT. Pancreatic nociception--revisiting the physiology and pathophysiology. Pancreatology. 2012;12:104-112. [PMID: 22487519 DOI: 10.1016/j.pan.2012.02.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
22 Afghani E, Sinha A, Singh VK. An overview of the diagnosis and management of nutrition in chronic pancreatitis. Nutr Clin Pract 2014;29:295-311. [PMID: 24743046 DOI: 10.1177/0884533614529996] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
23 Gardner TB, Adler DG, Forsmark CE, Sauer BG, Taylor JR, Whitcomb DC. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol. 2020;115:322-339. [PMID: 32022720 DOI: 10.14309/ajg.0000000000000535] [Cited by in Crossref: 53] [Cited by in F6Publishing: 30] [Article Influence: 53.0] [Reference Citation Analysis]
24 Arvanitakis M, Ockenga J, Bezmarevic M, Gianotti L, Krznarić Ž, Lobo DN, Löser C, Madl C, Meier R, Phillips M, Rasmussen HH, Van Hooft JE, Bischoff SC. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clinical Nutrition 2020;39:612-31. [DOI: 10.1016/j.clnu.2020.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 27.0] [Reference Citation Analysis]
25 Duggan SN. Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis. Proc Nutr Soc. 2017;76:484-494. [PMID: 28735575 DOI: 10.1017/s0029665117001045] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
26 Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol. 2013;19:7258-7266. [PMID: 24259956 DOI: 10.3748/wjg.v19.i42.7258] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 62] [Article Influence: 13.0] [Reference Citation Analysis]
27 Arutla M, Sarkar S, Unnisa M, Sarkar P, Raj MA, Mrudula MR, G D, Pasham S, Jakkampudi A, Prasanna A, Reddy DN, Talukdar R. Malnutrition after pancreatic enzyme replacement therapy in chronic pancreatitis: Risk factors in real world practice. Pancreatology 2021;21:34-41. [PMID: 33303371 DOI: 10.1016/j.pan.2020.11.027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC Med. 2017;15:29. [PMID: 28183317 DOI: 10.1186/s12916-017-0783-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 12.5] [Reference Citation Analysis]
29 Thorat V, Reddy N, Bhatia S, Bapaye A, Rajkumar JS, Kini DD, Kalla MM, Ramesh H. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2012;36:426-436. [PMID: 22762290 DOI: 10.1111/j.1365-2036.2012.05202.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
30 Gianotti L, Besselink MG, Sandini M, Hackert T, Conlon K, Gerritsen A, Griffin O, Fingerhut A, Probst P, Abu Hilal M, Marchegiani G, Nappo G, Zerbi A, Amodio A, Perinel J, Adham M, Raimondo M, Asbun HJ, Sato A, Takaori K, Shrikhande SV, Del Chiaro M, Bockhorn M, Izbicki JR, Dervenis C, Charnley RM, Martignoni ME, Friess H, de Pretis N, Radenkovic D, Montorsi M, Sarr MG, Vollmer CM, Frulloni L, Büchler MW, Bassi C. Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery 2018;164:1035-48. [PMID: 30029989 DOI: 10.1016/j.surg.2018.05.040] [Cited by in Crossref: 71] [Cited by in F6Publishing: 45] [Article Influence: 23.7] [Reference Citation Analysis]
31 Phillips ME, Hopper AD, Leeds JS, Roberts KJ, McGeeney L, Duggan SN, Kumar R. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterol 2021;8:e000643. [PMID: 34140324 DOI: 10.1136/bmjgast-2021-000643] [Reference Citation Analysis]
32 DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol. 2012;28:523-531. [PMID: 22782018 DOI: 10.1097/mog.0b013e3283567dea] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
33 de-Madaria E, Abad-gonzález A, Aparicio J, Aparisi L, Boadas J, Boix E, de-las-Heras G, Domínguez-muñoz E, Farré A, Fernández-cruz L, Gómez L, Iglesias-garcía J, García-malpartida K, Guarner L, Lariño-noia J, Lluís F, López A, Molero X, Moreno-pérez O, Navarro S, Palazón J, Pérez-mateo M, Sabater L, Sastre Y, Vaquero E, Martínez J. The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: Part 2 (treatment). Pancreatology 2013;13:18-28. [DOI: 10.1016/j.pan.2012.11.310] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
34 Sabater L, Ausania F, Bakker OJ, Boadas J, Domínguez-Muñoz JE, Falconi M, Fernández-Cruz L, Frulloni L, González-Sánchez V, Lariño-Noia J, Lindkvist B, Lluís F, Morera-Ocón F, Martín-Pérez E, Marra-López C, Moya-Herraiz Á, Neoptolemos JP, Pascual I, Pérez-Aisa Á, Pezzilli R, Ramia JM, Sánchez B, Molero X, Ruiz-Montesinos I, Vaquero EC, de-Madaria E. Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Ann Surg 2016;264:949-58. [PMID: 27045859 DOI: 10.1097/SLA.0000000000001732] [Cited by in Crossref: 53] [Cited by in F6Publishing: 12] [Article Influence: 13.3] [Reference Citation Analysis]
35 Juel CTB, Lund A, Andersen MM, Hansen CP, Storkholm JH, Rehfeld JF, van Hall G, Hartmann B, Wewer Albrechtsen NJ, Holst JJ, Vilsbøll T, Knop FK. The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial. Diabetologia 2020;63:1285-98. [DOI: 10.1007/s00125-020-05158-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Saito T, Hirano K, Isayama H, Nakai Y, Saito K, Umefune G, Akiyama D, Watanabe T, Takagi K, Hamada T, Takahara N, Uchino R, Mizuno S, Kogure H, Matsubara S, Yamamoto N, Tada M, Koike K. The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study. Pancreas 2017;46:341-6. [DOI: 10.1097/mpa.0000000000000767] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
37 Roberts KJ, Blanco G, Webber J, Marudanayagam R, Sutcliffe RP, Muiesan P, Bramhall SR, Isaac J, Mirza DF. How severe is diabetes after total pancreatectomy? HPB (Oxford). 2014;16:814-821. [PMID: 24344937 DOI: 10.1111/hpb.12203] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
38 Lindkvist B, Phillips ME, Domínguez-Muñoz JE. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use. Pancreatology 2015;15:589-97. [PMID: 26243045 DOI: 10.1016/j.pan.2015.07.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
39 Zdenkowski N, Radvan G, Pugliese L, Charlton J, Oldmeadow C, Fraser A, Bonaventura A. Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC). Support Care Cancer 2017;25:1963-71. [DOI: 10.1007/s00520-017-3602-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
40 Roberts KJ, Sheridan M, Morris-stiff G, Smith AM. Pancreaticopleural fistula: etiology, treatment and long-term follow-up. Hepatobiliary & Pancreatic Diseases International 2012;11:215-9. [DOI: 10.1016/s1499-3872(12)60151-9] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
41 Gregory PC, Hoffmann K, Kamphues J, Möeler A. The Pancreatic Duct Ligated (Mini)pig as a Model for Pancreatic Exocrine Insufficiency in Man. Pancreas 2016;45:1213-26. [PMID: 27623555 DOI: 10.1097/MPA.0000000000000674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
42 Silano V, Barat Baviera JM, Bolognesi C, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lambré C, Lampi E, Mengelers M, Mortensen A, Rivière G, Steffensen IL, Tlustos C, Van Loveren H, Vernis L, Zorn H, Gundert-Remy U, Herman L, Turck D, Kovalkovicova N, Liu Y, Maia J, Rainieri S, Chesson A; EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP). Safety evaluation of a food enzyme containing trypsin and chymotrypsin from porcine pancreas. EFSA J 2021;19:e06369. [PMID: 33437322 DOI: 10.2903/j.efsa.2021.6369] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Nakajima K, Oshida H, Muneyuki T, Kakei M. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency. Core Evid. 2012;7:77-91. [PMID: 22936895 DOI: 10.2147/ce.s26705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
44 Lambré C, Barat Baviera JM, Bolognesi C, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, Mengelers M, Mortensen A, Rivière G, Steffensen IL, Tlustos C, Van Loveren H, Vernis L, Zorn H, Gundert-Remy U, Herman L, Turck D, Engel KH, Aguilera-Gómez M, Andryszkiewicz M, Kovalkovicova N, Liu Y, Maia J, Rainieri S, Chesson A; EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP). Safety evaluation of food enzyme trypsin from porcine pancreas. EFSA J 2021;19:e06637. [PMID: 34178156 DOI: 10.2903/j.efsa.2021.6637] [Reference Citation Analysis]
45 Pathanki AM, Attard JA, Bradley E, Powell-Brett S, Dasari BVM, Isaac JR, Roberts KJ, Chatzizacharias NA. Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management. World J Gastrointest Pathophysiol 2020;11:20-31. [PMID: 32318312 DOI: 10.4291/wjgp.v11.i2.20] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Nofal YH, Abu Dail Y, Assaf Y, Abo Samra H, Abbas F, Hamzeh A, Alhaj Hasan N; Cochrane Upper GI and Pancreatic Diseases Group. Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012952] [Reference Citation Analysis]
47 Asensio-grau A, Calvo-lerma J, Heredia A, Andrés A. Fat digestibility in meat products: influence of food structure and gastrointestinal conditions. International Journal of Food Sciences and Nutrition 2019;70:530-9. [DOI: 10.1080/09637486.2018.1542665] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
48 Aloulou A, Schué M, Puccinelli D, Milano S, Delchambre C, Leblond Y, Laugier R, Carrière F. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency. Gastroenterology 2015;149:1910-1919.e5. [PMID: 26327131 DOI: 10.1053/j.gastro.2015.08.047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
49 Hart PA, Conwell DL. Challenges and updates in the management of exocrine pancreatic insufficiency. Pancreas. 2016;45:1-4. [PMID: 26658035 DOI: 10.1097/mpa.0000000000000457] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
50 de la Iglesia-García D, Huang W, Szatmary P, Baston-Rey I, Gonzalez-Lopez J, Prada-Ramallal G, Mukherjee R, Nunes QM, Domínguez-Muñoz JE, Sutton R; NIHR Pancreas Biomedical Research Unit Patient Advisory Group. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut 2017;66:1354-5. [PMID: 27941156 DOI: 10.1136/gutjnl-2016-312529] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
51 Herzig KH, Purhonen AK, Räsänen KM, Idziak J, Juvonen P, Phillps R, Walkowiak J. Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus. BMC Geriatr 2011;11:4. [PMID: 21266058 DOI: 10.1186/1471-2318-11-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
52 Ramesh H, Reddy N, Bhatia S, Rajkumar JS, Bapaye A, Kini D, Kalla M, Thorat V. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013;13:133-139. [PMID: 23561971 DOI: 10.1016/j.pan.2013.01.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
53 Sato T, Matsuo Y, Shiga K, Morimoto M, Miyai H, Takeyama H. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy. Surgery 2016;160:318-30. [DOI: 10.1016/j.surg.2016.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
54 Ueda J, Miyasaka Y, Ohtsuka T, Takahata S, Tanaka M. Short- and long-term results of the Frey procedure for chronic pancreatitis. J Hepatobiliary Pancreat Sci. 2015;22:211-216. [PMID: 25339262 DOI: 10.1002/jhbp.176] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
55 Yamazaki S, Takayama T, Higaki T, Moriguchi M, Yoshida N, Miyazaki T, Teshima Y. Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Gastroenterol 2016;51:55-62. [DOI: 10.1007/s00535-015-1077-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Mary F, Moesseler A, Khodorova N, Foucault-simonin A, Benamouzig R, Tomé D, Gregory PC, Gaudichon C. Metabolic markers of protein maldigestion after a 15 N test meal in minipigs with pancreatic exocrine insufficiency. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018;314:G223-30. [DOI: 10.1152/ajpgi.00218.2017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
57 Anderson MA, Akshintala V, Albers KM, Amann ST, Belfer I, Brand R, Chari S, Cote G, Davis BM, Frulloni L. Mechanism, assessment and management of pain in chronic pancreatitis: Recommendations of a multidisciplinary study group. Pancreatology. 2016;16:83-94. [PMID: 26620965 DOI: 10.1016/j.pan.2015.10.015] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
58 Han MM, Zhu XY, Peng YF, Lin H, Liu DC, Li L. The alterations of gut microbiota in mice with chronic pancreatitis. Ann Transl Med 2019;7:464. [PMID: 31700900 DOI: 10.21037/atm.2019.08.18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
59 Layer P, Kashirskaya N, Gubergrits N. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. World J Gastroenterol. 2019;25:2430-2441. [PMID: 31171887 DOI: 10.3748/wjg.v25.i20.2430] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
60 Kesseli SJ, Smith KA, Gardner TB. Total pancreatectomy with islet autologous transplantation: the cure for chronic pancreatitis? Clin Transl Gastroenterol. 2015;6:e73. [PMID: 25630865 DOI: 10.1038/ctg.2015.2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
61 Zhan W, Akshintala V, Greer PJ, Greer JB, Alkaade S, Anderson MA, Muniraj T, Papachristou GI, Sandhu BS, Slivka A, Wilcox CM, Bellin MD, Singh VK, Yadav D, Brand RE, Whitcomb DC; North American Pancreatic Study Group (NAPS2). Low serum trypsinogen levels in chronic pancreatitis: Correlation with parenchymal loss, exocrine pancreatic insufficiency, and diabetes but not CT-based cambridge severity scores for fibrosis. Pancreatology 2020;20:1368-78. [PMID: 32967795 DOI: 10.1016/j.pan.2020.08.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 González-Sánchez V, Amrani R, González V, Trigo C, Picó A, de-Madaria E. Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-Mixed Triglyceride Breath Test versus Fecal Elastase. Pancreatology 2017;17:580-5. [PMID: 28291656 DOI: 10.1016/j.pan.2017.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
63 Salhi A, Amara S, Mansuelle P, Puppo R, Lebrun R, Gontero B, Aloulou A, Carrière F. Characterization of all the lipolytic activities in pancreatin and comparison with porcine and human pancreatic juices. Biochimie 2020;169:106-20. [DOI: 10.1016/j.biochi.2019.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
64 Domínguez-Muñoz JE. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? Clin Gastroenterol Hepatol 2011;9:541-6. [PMID: 21377551 DOI: 10.1016/j.cgh.2011.02.027] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
65 Kim E, Kang JS, Han Y, Kim H, Kwon W, Kim JR, Kim SW, Jang JY. Influence of preoperative nutritional status on clinical outcomes after pancreatoduodenectomy. HPB (Oxford). 2018;20:1051-1061. [PMID: 29887259 DOI: 10.1016/j.hpb.2018.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
66 Berry AJ. Pancreatic Enzyme Replacement Therapy During Pancreatic Insufficiency. Nutr Clin Pract 2014;29:312-21. [DOI: 10.1177/0884533614527773] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
67 Pezzilli R, Caccialanza R, Capurso G, Brunetti O, Milella M, Falconi M. Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer.Cancers (Basel). 2020;12. [PMID: 31979186 DOI: 10.3390/cancers12020275] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
68 Shlieout G, Koerner A, Maffert M, Forssmann K, Caras S. Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study. Clin Drug Investig. 2011;31:e1-e7. [PMID: 21627335 DOI: 10.2165/11592990-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
69 Hata T, Ishida M, Motoi F, Sakata N, Yoshimatsu G, Naitoh T, Katayose Y, Egawa S, Unno M. Clinical Characteristics and Risk Factors for the Development of Postoperative Hepatic Steatosis After Total Pancreatectomy. Pancreas 2016;45:362-9. [PMID: 26495776 DOI: 10.1097/MPA.0000000000000462] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
70 Mikó A, Erőss B, Sarlós P, Hegyi P Jr, Márta K, Pécsi D, Vincze Á, Bódis B, Nemes O, Faluhelyi N, Farkas O, Papp R, Kelemen D, Szentesi A, Hegyi E, Papp M, Czakó L, Izbéki F, Gajdán L, Novák J, Sahin-Tóth M, Lerch MM, Neoptolemos J, Petersen OH, Hegyi P. Observational longitudinal multicentre investigation of acute pancreatitis (GOULASH PLUS): follow-up of the GOULASH study, protocol. BMJ Open 2019;9:e025500. [PMID: 31481363 DOI: 10.1136/bmjopen-2018-025500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Suzuki S, Miura J, Shimizu K, Tokushige K, Uchigata Y, Yamamoto M. Clinicophysiological outcomes after total pancreatectomy. Scandinavian Journal of Gastroenterology 2016;51:1526-31. [DOI: 10.1080/00365521.2016.1211173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
72 Bellin MD, Freeman ML, Gelrud A, Slivka A, Clavel A, Humar A, Schwarzenberg SJ, Lowe ME, Rickels MR, Whitcomb DC. Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest. Pancreatology. 2014;14:27-35. [PMID: 24555976 DOI: 10.1016/j.pan.2013.10.009] [Cited by in Crossref: 99] [Cited by in F6Publishing: 75] [Article Influence: 12.4] [Reference Citation Analysis]
73 Barkin JA, Barkin JS. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis. Pancreas 2021;50:176-82. [PMID: 33560089 DOI: 10.1097/MPA.0000000000001733] [Reference Citation Analysis]
74 Gan C, Chen YH, Liu L, Gao JH, Tong H, Tang CW, Liu R. Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: A meta-analysis. Oncotarget. 2017;8:94920-94931. [PMID: 29212278 DOI: 10.18632/oncotarget.21659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
75 Vujasinovic M, Valente R, Del Chiaro M, Permert J, Löhr JM. Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Nutrients 2017;9:E183. [PMID: 28241470 DOI: 10.3390/nu9030183] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 9.8] [Reference Citation Analysis]
76 Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55-73. [PMID: 21753892 DOI: 10.2147/ceg.s17634] [Cited by in Crossref: 13] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
77 O'Brien SJ, Omer E. Chronic Pancreatitis and Nutrition Therapy. Nutr Clin Pract 2019;34 Suppl 1:S13-26. [PMID: 31535736 DOI: 10.1002/ncp.10379] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
78 Paz-yépez C, Peinado I, Heredia A, Andrés A. Lipids digestibility and polyphenols release under in vitro digestion of dark, milk and white chocolate. Journal of Functional Foods 2019;52:196-203. [DOI: 10.1016/j.jff.2018.10.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
79 Carrato A, Cerezo L, Feliu J, Macarulla T, Martín-Pérez E, Vera R, Álvarez J, Botella-Carretero JI. Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clin Transl Oncol 2021. [PMID: 34363594 DOI: 10.1007/s12094-021-02674-x] [Reference Citation Analysis]
80 Takemura N, Saiura A, Koga R, Yamamoto J, Yamaguchi T. Risk Factors for and Management of Postpancreatectomy Hepatic Steatosis. Scand J Surg 2017;106:224-9. [DOI: 10.1177/1457496916669630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
81 Kishi Y, Shimada K, Nara S, Esaki M, Kosuge T. Administration of Pancrelipase as Effective Treatment for Hepatic Steatosis After Pancreatectomy. Pancreas 2015;44:983-7. [DOI: 10.1097/mpa.0000000000000356] [Cited by in Crossref: 12] [Article Influence: 2.0] [Reference Citation Analysis]
82 Bartel MJ, Asbun H, Stauffer J, Raimondo M. Pancreatic exocrine insufficiency in pancreatic cancer: A review of the literature. Dig Liver Dis. 2015;47:1013-1020. [PMID: 26211872 DOI: 10.1016/j.dld.2015.06.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
83 D'Haese JG, Ceyhan GO, Demir IE, Layer P, Uhl W, Löhr M, Rychlik R, Pirilis K, Zöllner Y, Gradl B, Foerster D, Möbius J, Henniges F, Friess H. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life. Pancreas 2014;43:834-41. [PMID: 24717829 DOI: 10.1097/MPA.0000000000000131] [Cited by in Crossref: 46] [Cited by in F6Publishing: 11] [Article Influence: 7.7] [Reference Citation Analysis]
84 Burton F, Alkaade S, Collins D, Muddana V, Slivka A, Brand RE, Gelrud A, Banks PA, Sherman S, Anderson MA. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. Aliment Pharmacol Ther. 2011;33:149-159. [PMID: 21083584 DOI: 10.1111/j.1365-2036.2010.04491.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
85 Barkin JA, Westermann A, Hoos W, Moravek C, Matrisian L, Wang H, Shemanski L, Barkin JS, Rahib L. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.Pancreas. 2019;48:780-786. [PMID: 31210656 DOI: 10.1097/MPA.0000000000001330] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
86 Nagai M, Sho M, Satoi S, Toyokawa H, Akahori T, Yanagimoto H, Yamamoto T, Hirooka S, Yamaki S, Kinoshita S. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2014;21:186-192. [PMID: 23798362 DOI: 10.1002/jhbp.14] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
87 Giuliano CA, Dehoorne-Smith ML, Kale-Pradhan PB. Pancreatic enzyme products: digesting the changes. Ann Pharmacother 2011;45:658-66. [PMID: 21540403 DOI: 10.1345/aph.1P770] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
88 Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, Rahib L; Precision Promise Consortium. Pancreas Cancer-Associated Weight Loss. Oncologist 2019;24:691-701. [PMID: 30591550 DOI: 10.1634/theoncologist.2018-0266] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
89 Hobbs PM, Johnson WG, Graham DY. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes. World J Gastrointest Pharmacol Ther 2016;7:370-86. [PMID: 27602238 DOI: 10.4292/wjgpt.v7.i3.370] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]